Literature DB >> 29055006

Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip.

Smita Kulkarni1,2, Veron Ramsuran3,4,5,6, Marijana Rucevic3, Sukhvinder Singh2, Alexandra Lied3, Viraj Kulkarni3,7, Colm O'hUigin4, Sylvie Le Gall3, Mary Carrington3,4.   

Abstract

Genomic variation in the untranslated region (UTR) has been shown to influence HLA class I expression level and associate with disease outcomes. Sequencing of the 3'UTR of common HLA-A alleles indicated the presence of two polyadenylation signals (PAS). The proximal PAS is conserved, whereas the distal PAS is disrupted within certain alleles by sequence variants. Using 3'RACE, we confirmed expression of two distinct forms of the HLA-A 3'UTR based on use of either the proximal or the distal PAS, which differ in length by 100 bp. Specific HLA-A alleles varied in the usage of the proximal versus distal PAS, with some alleles using only the proximal PAS, and others using both the proximal and distal PAS to differing degrees. We show that the short and the long 3'UTR produced similar mRNA expression levels. However, the long 3'UTR conferred lower luciferase activity as compared with the short form, indicating translation inhibition of the long 3'UTR. RNA affinity pull-down followed by mass spectrometry analysis as well as RNA coimmunoprecipitation indicated differential binding of Syncrip to the long versus short 3'UTR. Depletion of Syncrip by small interfering RNA increased surface expression of an HLA-A allotype that uses primarily the long 3'UTR, whereas an allotype expressing only the short form was unaffected. Furthermore, specific blocking of the proximal 3'UTR reduced surface expression without decreasing mRNA expression. These data demonstrate HLA-A allele-specific variation in PAS usage, which modulates their cell surface expression posttranscriptionally.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055006      PMCID: PMC5812486          DOI: 10.4049/jimmunol.1700697

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex.

Authors:  C Grosset; C Y Chen; N Xu; N Sonenberg; H Jacquemin-Sablon; A B Shyu
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

2.  Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

4.  The acidic domain of hnRNPQ (NSAP1) has structural similarity to Barstar and binds to Apobec1.

Authors:  Alexandre J C Quaresma; Sergio Oyama; João A R G Barbosa; Jörg Kobarg
Journal:  Biochem Biophys Res Commun       Date:  2006-09-18       Impact factor: 3.575

5.  Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.

Authors:  V Blanc; N Navaratnam; J O Henderson; S Anant; S Kennedy; A Jarmuz; J Scott; N O Davidson
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

6.  Transcriptional activators enhance polyadenylation of mRNA precursors.

Authors:  Takashi Nagaike; Charlotte Logan; Ikuko Hotta; Orit Rozenblatt-Rosen; Matthew Meyerson; James L Manley
Journal:  Mol Cell       Date:  2011-02-18       Impact factor: 17.970

7.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Theodore A Gooley; Mari Malkki; Andrea P Bacigalupo; Anne Cesbron; Ernette Du Toit; Gerhard Ehninger; Torstein Egeland; Gottfried F Fischer; Thibaut Gervais; Michael D Haagenson; Mary M Horowitz; Katharine Hsu; Pavel Jindra; Alejandro Madrigal; Machteld Oudshoorn; Olle Ringdén; Marlis L Schroeder; Stephen R Spellman; Jean-Marie Tiercy; Andrea Velardi; Campbell S Witt; Colm O'Huigin; Richard Apps; Mary Carrington
Journal:  Blood       Date:  2014-10-16       Impact factor: 22.113

8.  Regulation of alternative polyadenylation by genomic imprinting.

Authors:  Andrew J Wood; Reiner Schulz; Kathryn Woodfine; Katarzyna Koltowska; Colin V Beechey; Jo Peters; Deborah Bourc'his; Rebecca J Oakey
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

9.  Heterogenous nuclear ribonucleoprotein Q increases protein expression from HIV-1 Rev-dependent transcripts.

Authors:  Michelle Vincendeau; Daniel Nagel; Jara K Brenke; Ruth Brack-Werner; Kamyar Hadian
Journal:  Virol J       Date:  2013-05-16       Impact factor: 4.099

10.  Drosophila Syncrip binds the gurken mRNA localisation signal and regulates localised transcripts during axis specification.

Authors:  Suzanne M McDermott; Carine Meignin; Juri Rappsilber; Ilan Davis
Journal:  Biol Open       Date:  2012-04-11       Impact factor: 2.422

View more
  12 in total

Review 1.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

2.  SYNCRIP facilitates porcine parvovirus viral DNA replication through the alternative splicing of NS1 mRNA to promote NS2 mRNA formation.

Authors:  Songbiao Chen; Bichen Miao; Nannan Chen; Caiyi Chen; Ting Shao; Xuezhi Zhang; Lingling Chang; Xiujuan Zhang; Qian Du; Yong Huang; Dewen Tong
Journal:  Vet Res       Date:  2021-05-25       Impact factor: 3.683

3.  Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.

Authors:  Michael Friedrich; Christoforos K Vaxevanis; Katharina Biehl; Anja Mueller; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

Review 4.  Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis.

Authors:  Amit Kishore; Martin Petrek
Journal:  Front Genet       Date:  2018-10-25       Impact factor: 4.599

5.  The Length of the Expressed 3' UTR Is an Intermediate Molecular Phenotype Linking Genetic Variants to Complex Diseases.

Authors:  Elisa Mariella; Federico Marotta; Elena Grassi; Stefano Gilotto; Paolo Provero
Journal:  Front Genet       Date:  2019-08-16       Impact factor: 4.599

6.  Complete characterization of the human immune cell transcriptome using accurate full-length cDNA sequencing.

Authors:  Charles Cole; Ashley Byrne; Matthew Adams; Roger Volden; Christopher Vollmers
Journal:  Genome Res       Date:  2020-04-20       Impact factor: 9.043

7.  Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis.

Authors:  Jingru Fang; Colette Pietzsch; Palaniappan Ramanathan; Rodrigo I Santos; Philipp A Ilinykh; Mariano A Garcia-Blanco; Alexander Bukreyev; Shelton S Bradrick
Journal:  MBio       Date:  2018-10-09       Impact factor: 7.867

8.  Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.

Authors:  Thuja Meurer; Esteban Arrieta-Bolaños; Maximilian Metzing; Mona-May Langer; Peter van Balen; J H Frederik Falkenburg; Dietrich W Beelen; Peter A Horn; Katharina Fleischhauer; Pietro Crivello
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

9.  Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Authors:  Jukka Partanen; Kati Hyvärinen; Heike Bickeböller; Katarzyna Bogunia-Kubik; Rachel E Crossland; Milena Ivanova; Francesca Perutelli; Ralf Dressel
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

10.  Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Authors:  Maria-Filothei Lazaridou; Evamaria Gonschorek; Chiara Massa; Michael Friedrich; Diana Handke; Anja Mueller; Simon Jasinski-Bergner; Reinhard Dummer; Peter Koelblinger; Barbara Seliger
Journal:  Oncoimmunology       Date:  2020-06-03       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.